EPICS Biotechnology is pioneering plant-based biofactories to produce bioactive compounds for sustainable, non-GMO crop protection. This approach offers cost-effective alternatives to synthetic pesticides and biostimulants, addressing global agricultural challenges.
EPICS Biotechnology is at the forefront of transforming agriculture through the innovative use of plant-based biofactories. By engineering plants such as Camelina sativa and Nicotiana benthamiana to naturally produce high-value bioactive compounds, this approach provides a sustainable, cost-effective alternative to synthetic pesticides and biostimulants. The solution addresses the challenges of pest resistance, regulatory bans, and consumer concerns over GMOs, offering a scalable, non-GMO method for efficient crop protection.
Key Features:
Currently at Technology Readiness Level 4, this technology has demonstrated proof of concept in engineered plants. Ongoing validation includes optimization of protein yield and stability, efficacy trials, and field testing. The future phases involve scaling the production, conducting field trials, and navigating the regulatory pathway for commercialization.
EPICS Biotechnology is a biotech company focused on developing plant-based solutions for sustainable agriculture through innovative molecular agronomy and protein engineering.